Third Pole Therapeutics IPO

Third Pole Therapeutics is a biotechnology company that is developing and commercializing novel, portable inhaled nitric oxide (iNO) delivery systems for the treatment of pulmonary hypertension and other cardio-pulmonary diseases. The company's proprietary technology, known as the iNOvent™ platform, enables on-demand, targeted delivery of iNO to patients in a variety of settings, including hospitals, clinics, and homes. Third Pole Therapeutics aims to improve patient outcomes and quality of life by providing safe, effective, and accessible iNO therapy.

Register for Details

For more details on financing and valuation for Third Pole Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Third Pole Therapeutics's ticker symbol?

Third Pole Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Third Pole Therapeutics's stock price?

The stock price for Third Pole Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Third Pole Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
2/16/2023 Series B-1, B-2, B-3, and B-4 $149.72MM raised $XXX.XX $XXX.XX
12/18/2015 Series A $17.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Third Pole Therapeutics

Forge green plus iconForge green minus icon

What is Third Pole Therapeutics funding to date?

Third Pole Therapeutics has raised $167.22MM with the following series:
$17.5MM raised for Series A,$149.72MM raised for Series B-1, B-2, B-3, and B-4.
Forge green plus iconForge green minus icon

When was Third Pole Therapeutics founded?

Third Pole Therapeutics was founded in 2014.
Forge green plus iconForge green minus icon

Can you invest in Third Pole Therapeutics?

Third Pole Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Third Pole Therapeutics share pre-IPO?

If you own Third Pole Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Third Pole Therapeutics a publicly traded company?

Third Pole Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Third Pole Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B